The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interrogating acquired PD-1 resistance through BET bromodomain inhibition in hepatocellular carcinoma murine models.
 
Carlotta Pazzi
No Relationships to Disclose
 
S. Daniel Haldar
Consulting or Advisory Role - HMP Education; Sift Biosciences
Research Funding - Bristol Myers Squibb (Inst); Shionogi (Inst); Summit Therapeutics (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Tamara Lopez-Vidal
No Relationships to Disclose
 
Alyza Skaist
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Anuj Gupta
No Relationships to Disclose
 
Nicole Gross
No Relationships to Disclose
 
Soren Charmsaz
No Relationships to Disclose
 
Alexei Hernandez
No Relationships to Disclose
 
James Leatherman
No Relationships to Disclose
 
Won Jin Ho
Honoraria - Standard Biotools
Consulting or Advisory Role - Delcath Systems
Research Funding - Riboscience (Inst); Riboscience (Inst)
Patents, Royalties, Other Intellectual Property - I hold patents and receive royalties from Rodeo Therapeutics.
 
Nilo Azad
Stock and Other Ownership Interests - Cage Pharma; Haystack Oncology/Quest; Irazu
Honoraria - Agenus; Astellas Amgen BioPharama; AstraZeneca; BeiGene; GlaxoSmithKline; Incyte; Lilly; Revolution Medicines; Tempus
Consulting or Advisory Role - Agenus; Astellas Oncology; AstraZeneca; BeiGene; GlaxoSmithKline; Incyte; Lilly; Revolution Medicines; Tempus
Research Funding - AstraZeneca; Atlas Antibodies; Bayer; BeiGene; Compass Oncology; Incyte; Mirati Therapeutics/Bristol-Myers Squibb; Pfizer/Seagen; Revolution Medicines; Syndax; Taiho Oncology
 
Mark Yarchoan
Leadership - Adventris Pharmaceuticals
Stock and Other Ownership Interests - Adventris Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Exelixis; Genentech/Roche; Incyte; Lantheus Medical Imaging
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to therapeutic cancer vaccines, managed by Johns Hopkins
Travel, Accommodations, Expenses - Genentech/Roche/imCORE
 
Marina Baretti
Consulting or Advisory Role - AstraZeneca; Incyte
Research Funding - Merck (Inst)